What top creators are saying about Spruce Biosciences(SPRB)
A biopharmaceutical company.
5 AI-extracted insights from 1 source — podcasts, YouTube channels, and X/Twitter accounts.
Creator sentiment — last 30 days
Not enough scored insights about Spruce Biosciences in the last 30 days yet.
Top creators covering Spruce Biosciences (SPRB)
The 1 sources with the most insights about Spruce Biosciences on Kazuha.
Latest insights about Spruce Biosciences (SPRB)
AI-generated insights from podcasts, YouTube videos, and X posts — ordered by most recent.
Tuesday, May 5, 2026
Maintains a bullish stance despite market fluctuations, citing massive upside potential.
Friday, March 20, 2026
Described as a '10x' opportunity and 'no-brainer'; potential for a $100M Priority Review Voucher (PRV) sale.
Tuesday, November 18, 2025
The speaker is 'over the moon about' this stock and confirms they are 'still long', indicating a strong bullish conviction.
Thursday, October 16, 2025
The host gave a direct buy recommendation, stating 'I think it's still a buy. Spruce is still a buy.'
Tuesday, October 14, 2025
The speaker is very confident in long-term potential, believing it could be a $1,000 stock. The main risk is initial FDA approval, but ultimate approval is expected. A price below $100 is seen as a buying opportunity.
Tuesday, May 5, 2026
Maintains a bullish stance despite market fluctuations, citing massive upside potential.
Friday, March 20, 2026
Described as a '10x' opportunity and 'no-brainer'; potential for a $100M Priority Review Voucher (PRV) sale.
Tuesday, November 18, 2025
The speaker is 'over the moon about' this stock and confirms they are 'still long', indicating a strong bullish conviction.
Thursday, October 16, 2025
The host gave a direct buy recommendation, stating 'I think it's still a buy. Spruce is still a buy.'
Tuesday, October 14, 2025
The speaker is very confident in long-term potential, believing it could be a $1,000 stock. The main risk is initial FDA approval, but ultimate approval is expected. A price below $100 is seen as a buying opportunity.
Discussed alongside Spruce Biosciences (SPRB)
Other assets that creators frequently mention in the same content as Spruce Biosciences.
Frequently asked
Which podcasters and creators cover Spruce Biosciences (SPRB) the most?
The most active sources covering Spruce Biosciences (SPRB) on Kazuha are @realmartinshkreli. Kazuha aggregates AI-extracted insights from podcasts, YouTube channels, and X/Twitter accounts.
How many insights about Spruce Biosciences (SPRB) are on Kazuha?
Kazuha has indexed 5 AI-extracted insights about Spruce Biosciences (SPRB) from 1 different source. New insights are added whenever a covered creator publishes a new podcast episode, video, or post.
What other assets do creators discuss alongside Spruce Biosciences (SPRB)?
Creators covering Spruce Biosciences (SPRB) most frequently also discuss IONQ, SRPT, RGTI, INTC, NVO. See the "Discussed alongside" section above for full asset pages.